NKTR: Nektar Therapeutics Stock

by  •  • Comments Off on NKTR: Nektar Therapeutics Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 330.52
Enterprise Value ($M) 399.74
Book Value ($M) 126.70
Book Value / Share 0.69
Price / Book 2.61
NCAV ($M) 50.53
NCAV / Share 0.28
Price / NCAV 6.54

Profitability (mra)
Return on Invested Capital (ROIC) -0.49
Return on Assets (ROA) -0.31
Return on Equity (ROE) -0.73

Liquidity (mrq)
Quick Ratio 5.79
Current Ratio 6.10

Balance Sheet (mrq) ($M)
Current Assets 319.84
Assets 396.01
Liabilities 269.31
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 90.12
Operating Income -135.22
Net Income -276.06
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -192.61
Cash from Investing 139.56
Cash from Financing 0.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-15 13G TCG Crossover GP II, LLC 9.90
02-14 13G/A Citadel Advisors Llc 3.00
02-14 13G/A Deep Track Capital, LP 9.65 49.57
02-14 13G/A Ra Capital Management, L.p. 0.00 -100.00
02-13 13G/A Vanguard Group Inc 6.31 -0.11
07-10 13G/A Invesco Ltd. 2.90 -85.17
07-07 13G/A BlackRock Inc. 4.50 -52.98
07-07 13G/A Primecap Management Co/ca/ 4.31 -47.95

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-05 10-K w UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For th

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 115,969 1,074,552 10.79
2024-05-16 153,722 1,427,614 10.77
2024-05-15 196,126 1,299,703 15.09
2024-05-14 173,281 351,180 49.34
2024-05-13 312,987 3,032,911 10.32

(click for more detail)

Similar Companies
NATR – Nature's Sunshine Products, Inc. NERV – Minerva Neurosciences, Inc.
NEXI – NexImmune, Inc. NLSP – NLS Pharmaceutics Ltd.
NRBO – NeuroBo Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io